A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.

[1]  N. Weiner,et al.  Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. , 2010, Journal of pharmaceutical sciences.

[2]  E. Warshaw,et al.  Positive Patch‐Test Reactions to Propylene Glycol: A Retrospective Cross‐Sectional Analysis from the North American Contact Dermatitis Group, 1996 to 2006 , 2009, Dermatitis : contact, atopic, occupational, drug.

[3]  W. Bergfeld,et al.  The clinical evaluation of hirsutism , 2008, Dermatologic therapy.

[4]  E. Olsen,et al.  A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. , 2007, Journal of the American Academy of Dermatology.

[5]  J. Lademann,et al.  Follicular Penetration of Topically Applied Caffeine via a Shampoo Formulation , 2007, Skin Pharmacology and Physiology.

[6]  J. Geier,et al.  Skin‐sensitizing and irritant properties of propylene glycol , 2005, Contact dermatitis.

[7]  D. Piacquadio,et al.  A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. , 2004, Journal of the American Academy of Dermatology.

[8]  J. Rundegren,et al.  Minoxidil: mechanisms of action on hair growth , 2004, The British journal of dermatology.

[9]  E. Olsen,et al.  A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. , 2002, Journal of the American Academy of Dermatology.

[10]  M. P. Birch,et al.  Hair density, hair diameter and the prevalence of female pattern hair loss , 2001, The British journal of dermatology.

[11]  E. Olsen.  The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. , 1999, Journal of the American Academy of Dermatology.

[12]  D. Canfield.  PHOTOGRAPHIC DOCUMENTATION OF HAIR GROWTH IN ANDROGENETIC ALOPECIA , 1996 .

[13]  M. Warner,et al.  Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. , 1994, Archives of dermatology.

[14]  M. Warner,et al.  USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN , 1993, International journal of dermatology.

[15]  James R. Spinaler.  The safety of topical minoxidil solution in the treatment of pattern baldness: The results of a 27-center trial , 1988 .

[16]  V. Venning,et al.  Patterned androgenic alopecia in women. , 1988, Journal of the American Academy of Dermatology.